STOCK TITAN
  1. Home
  2. Sec-filings
  3. GILD
  4. [Form 4] GILEAD SCIENCES, INC. Insider Trading Activity

Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Gilead Sciences Chief Financial Officer Andrew D. Dickinson reported routine equity compensation activity. On June 10, 2026, he exercised restricted stock units covering 2,796 shares of common stock at a conversion price of $0.00 per share.

To cover tax obligations, 1,341 shares of common stock were disposed of as a tax-withholding transaction at $121.48 per share, rather than through an open-market sale. Following these transactions, he holds 175,987 shares of Gilead common stock directly and 27,851 restricted stock units, which vest over a four-year schedule.

Positive

  • None.

Negative

  • None.
Insider Dickinson Andrew D
Role Chief Financial Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 2,796 $0.00 --
Exercise Common Stock 2,796 $0.00 --
Tax Withholding Common Stock 1,341 $121.48 $163K
Holdings After Transaction: Restricted Stock Unit — 27,851 shares (Direct, null); Common Stock — 175,987 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
RSUs exercised 2,796 shares Restricted stock units converted to common stock on June 10, 2026
Tax-withholding shares 1,341 shares Shares disposed of to satisfy tax obligations
Tax-withholding price $121.48 per share Value used for tax-withholding disposition
Common shares held after 175,987 shares Direct Gilead common stock ownership after transactions
RSUs outstanding after 27,851 units Restricted stock units remaining after the reported exercise
Exercise price $0.00 per share Conversion price for restricted stock units into common stock
Restricted Stock Unit financial
"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
4-year vesting schedule financial
"The restricted stock units have a 4-year vesting schedule."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dickinson Andrew D
(Last)(First)(Middle)
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
(Street)
FOSTER CITY CALIFORNIA 94404
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026M2,796A(1)175,987D
Common Stock06/10/2026F1,341D$121.48174,646D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/10/2026M2,796 (2) (2)Common Stock2,796(1)27,851D
Explanation of Responses:
1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Remarks:
/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Gilead (GILD) CFO Andrew Dickinson report?

Gilead CFO Andrew Dickinson reported exercising 2,796 restricted stock units into common shares and a related tax-withholding disposition of 1,341 shares. These actions reflect routine equity compensation events rather than open-market buying or selling of Gilead stock.

How many Gilead (GILD) shares does the CFO hold after this Form 4 filing?

After the reported transactions, Andrew Dickinson directly holds 175,987 shares of Gilead common stock. He also has 27,851 restricted stock units outstanding, which represent additional potential shares that will be delivered as they vest over time.

Was the Gilead (GILD) CFO’s Form 4 transaction an open-market sale?

The Form 4 shows a tax-withholding disposition of 1,341 shares at $121.48 per share, not an open-market sale. These shares were withheld to satisfy tax obligations associated with vesting restricted stock units, a common feature of equity compensation.

What restricted stock unit activity did Gilead (GILD) disclose for its CFO?

The filing shows Andrew Dickinson converted 2,796 restricted stock units into common stock at a $0.00 conversion price. After this derivative exercise, he still holds 27,851 restricted stock units, subject to a four-year vesting schedule with quarterly vesting after the first year.

How do Gilead (GILD) CFO’s restricted stock units vest over time?

Each restricted stock unit represents the right to receive one Gilead common share. The units vest over four years: 25% on the first anniversary of the grant date, with the remaining balance vesting 6.25% quarterly thereafter until fully vested, if service conditions are met.

Does the Gilead (GILD) CFO’s Form 4 indicate net buying or selling of shares?

The Form 4 reflects both acquisition and disposition components, resulting in a neutral net buy/sell position. It combines a derivative exercise of 2,796 restricted stock units with a 1,341-share tax-withholding disposition, typical of routine compensation-related equity vesting.